Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its access have become key issues for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its expensive nature presents a significant challenge to many. Disc